Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 301–350 of 635 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04857528	Detecting HPV DNA in Anal and Cervical Cancers	recruiting	—	20	University of ChicagoOTHER	1	Mar 4, 2026	clinicaltrials
NCT03403465	Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers	active not recruiting	Phase 2	90	Duke UniversityOTHER	1	Feb 27, 2026	clinicaltrials